Advances in R/R Multiple Myeloma: Practical Guidance for Newly Approved and Emerging Therapies

Gain expert pharmacist perspective on newly approved and emerging therapies for relapsed/refractory multiple myeloma with a webcast of a live webinar plus downloadable slidesets.

Share

Program Content

No activities added yet

Activities

Advances in R/R MM
Advances in Relapsed/Refractory Multiple Myeloma: Practical Guidance for Newly Approved and Emerging Therapies
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 04, 2021

Expires: May 03, 2022

<i>EP</i>: R/R MM
ExpressPoints
Advances in Relapsed/Refractory Myeloma: Practical Guidance for Newly Approved and Emerging Therapies
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 14, 2021

Expires: May 13, 2022

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

Bristol Myers Squibb

Karyopharm Therapeutics